Pacira Pharmaceuticals Q2 2019 Earnings Preview

|About: Pacira BioSciences, Inc. (PCRX)|By:, SA News Editor

Pacira Pharmaceuticals (NASDAQ:PCRX) is scheduled to announce Q2 earnings results on Thursday, August 8th, before market open.

The consensus EPS Estimate is $0.34 (+41.7% Y/Y) and the consensus Revenue Estimate is $99.92M (+18.8% Y/Y).

Over the last 2 years, pcrx has beaten EPS estimates 50% of the time and has beaten revenue estimates 50% of the time.

Over the last 3 months, EPS estimates have seen 6 upward revisions and 6 downward. Revenue estimates have seen 10 upward revisions and 3 downward.

Subscribe for full text news in your inbox